Tenaya Therapeutics
Tenaya Therapeutics

Tenaya Therapeutics

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

2016Active99South San Francisco, United States

Check the tech stack behind tenayatherapeutics.com. Find a founder email at tenayatherapeutics.com.

About

Tenaya Therapeutics is a clinical-stage biotechnology company dedicated to discovering, designing, developing, and delivering potentially curative gene therapies for heart disease. Their lead programs, TN-201 and TN-401, target MYBPC3-associated hypertrophic cardiomyopathy (HCM) and PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC), respectively. They aim to address the underlying drivers of these debilitating conditions to improve and extend the lives of patients and their families. Teams look it up for Biotech, MedTech, HealthTech.

Frequently asked

What does Tenaya Therapeutics do?

Tenaya Therapeutics is a Biotech company that offers Platform. Teams look it up for MedTech, HealthTech, Genomics. It is based in South San Francisco, United States and was founded in 2016. Public records show about 99 people and $159M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.

How much funding has Tenaya Therapeutics raised?

Tenaya Therapeutics has raised a total of $159M in funding. The most recent round on record is Public Offering.

Where is Tenaya Therapeutics headquartered?

Tenaya Therapeutics is headquartered in South San Francisco, United States.

When was Tenaya Therapeutics founded?

Tenaya Therapeutics was founded in 2016.

What industry does Tenaya Therapeutics operate in?

Tenaya Therapeutics operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery.

How many employees does Tenaya Therapeutics have?

Tenaya Therapeutics has approximately 99 people on record.

Scores
Measured, not editorial
Ahrefs DR
44/100

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Agent Readiness
32/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Site Speed
59/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Add first review